Vitasora Health Limited (VHL, formerly Respiri Limited) is an international e-Health SaaS company supporting respiratory health management focusing primarily on supporting the US remote patient monitoring market. Its technology detects wheeze, a typical symptom of Asthma, COPD and respiratory disease to provide an objective measure of airway limitation. Vitasora Health created technology optimises how patients in partnership with their physicians manage chronic respiratory conditions.
Find out what a historical investment in Vitasora Health would be worth today using our VHL stock calculator.
Buying VHL shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Vitasora Health in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in VHL
What is the ticker symbol of Vitasora Health?
The ticker symbol for Vitasora Health is VHL.
How much is one share of VHL?
One share of VHL is valued at $0.01 as of 20 November 2026.
What is the market capitalisation of Vitasora Health VHL?
As of 20 November 2026 Vitasora Health has a market cap of $25.84M.
What is the P/E ratio of VHL?
The Price to Earnings ratio of VHL is -1.72.
What is the Earnings Per Share of VHL?
The Earnings Per Share of VHL is -$0.01.
What is the 52-week high for Vitasora Health stock?
The Vitasora Health 52-week high stock price is $0.03.
What is the 52-week low for Vitasora Health stock?
The Vitasora Health 52-week low stock price is $0.01.
Can I buy VHL shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy VHL shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.